ArticleCureus2024

New Mediastinal and Hilar Lymphadenopathy After Adjuvant Pembrolizumab in a Patient With Stage III Clear Cell Renal Cell Carcinoma.

Matthew Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.